PT  - JOURNAL ARTICLE
AU  - Martin-Blondel, Guillaume
AU  - Alvarez, Muriel
AU  - Delobel, Pierre
AU  - Uro-Coste, Emmanuelle
AU  - Cuzin, Lise
AU  - Cuvinciuc, Victor
AU  - Fillaux, Judith
AU  - Massip, Patrice
AU  - Marchou, Bruno
TI  - Toxoplasmic encephalitis IRIS in HIV-infected patients: a case series and review of the literature
AID  - 10.1136/jnnp.2009.199919
DP  - 2011 Jun 01
TA  - Journal of Neurology, Neurosurgery & Psychiatry
PG  - 691--693
VI  - 82
IP  - 6
4099  - http://jnnp.bmj.com/content/82/6/691.short
4100  - http://jnnp.bmj.com/content/82/6/691.full
SO  - J Neurol Neurosurg Psychiatry2011 Jun 01; 82
AB  - Background Toxoplasmic encephalitis associated with immune reconstitution inflammatory syndrome (TE-IRIS) is rarely described.Methods To identify TE-IRIS cases, the authors performed a retrospective study of all HIV-infected patients diagnosed as having TE in our unit between January 2000 and June 2009, and a review of published cases.Results Three patients out of 65 toxoplasmic encephalitis (TE) cases, together with six from the literature, fulfilled the unmasking TE-IRIS definition. None fulfilled the paradoxical TE-IRIS definition. TE occurred within a median time of 48.5 days (IQ25–75 21–56) after starting antiretroviral therapy. Cases did not have distinctive clinical or neuroimaging features from TE occurring without immune reconstitution. However: (1) cases occurred at a median CD4 lymphocytes count of 222/μl (IQ25–75 160–280); (2) TE occurred in five patients who were supposed to take an effective chemoprophylaxis; (3) two patients had a brain biopsy showing an intense angiocentric inflammatory infiltrating with predominantly CD8 lymphocytes; (4) in one patient, the abnormal length of evolution under treatment might be due to the heightened immune response.Conclusion Although rare, unmasking TE-IRIS exists and might occur despite effective prophylaxis and an unusually high CD4 lymphocyte count. Immune reconstitution inflammatory syndrome does not modify TE diagnosis and treatment but might extend its clinical course.